RARRES2 and glioblastoma: Moreover, the inhibition of NF-κB signaling remarkably decreased mesenchymal marker expression in chemerin-overexpressing GSCs (Fig. 5E), suggesting the involvement of NF-κB signaling in chemerin-mediated enhancement of mesenchymal features in GBM cells.